Aspirin protects men over 60 from prostate cancer, study saysBMJ 2002; 324 doi: https://doi.org/10.1136/bmj.324.7339.696/c (Published 23 March 2002) Cite this as: BMJ 2002;324:696
- Scott Gottlieb
- New York
Regular use of aspirin, ibuprofen, and other non-steroidal anti-inflammatory drugs may protect against the development of prostate cancer in older men, says a study in the United States.
Men aged over 60 who took a daily dose of one of the drugs known collectively as non-steroidal anti-inflammatory drugs (NSAIDs) were half as likely to develop the disease.
The six year study of 1362 white men in Minnesota aged 50 to 79 found that 4% of men who took the drugs developed prostate cancer, compared with 9% of the control group (Mayo Clinic Proceedings 2002;77:219-25). The older the patient, the …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial